Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury - PubMed (original) (raw)
Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury
S K Agrawal et al. J Neurosci. 1997.
Abstract
We examined the role of glutamatergic mechanisms in acute injury to rat spinal cord white matter. Compound action potentials (CAPs) were recorded from isolated dorsal column segments in vitro. Under control conditions (Ringer's solution), the CAPs decreased to 71.4 +/- 2.0% of preinjury values after compression injury with a clip exerting a closing force of 2 g. The combination of the NMDA receptor blocker APV (50 microM) and the AMPA/kainate (KA) receptor blocker CNQX (10 microM) resulted in significantly improved recovery of CAP amplitude postinjury; however, the NMDA receptor antagonist APV alone did not enhance postinjury recovery, and infusion of NMDA (10 microM) did not affect recovery of the CAPs. In contrast, the AMPA/KA receptor blockers NBQX (10 microM) or CNQX (10 microM) significantly enhanced the recovery of CAP amplitude postinjury. The agonists AMPA (100 microM) or KA (100 microM) resulted in significant attenuation of CAP amplitude postinjury. Coapplication of AMPA/KA plus NBQX and CNQX was also associated with improved functional recovery. After incubation with AMPA and KA, Co(2+)-positive glia were visualized in spinal cord white matter. Similar results were seen after compressive injury but not in control cords. Immunohistochemistry and Western blot analysis demonstrated AMPA (GluR4)- and KA (GluR6/7 and KA2)-positive astrocytes in spinal cord white matter. In summary, non-NMDA ionotropic glutamate receptors seem to be involved in the pathophysiology of traumatic spinal cord injury. The presence of AMPA (GluR4) and KA (GluR6/7 and KA2) receptors on periaxonal astrocytes suggests a role for these cells in glutamatergic white matter injury.
Figures
Fig. 6.
a, Western blot illustrating MAP2 presence in whole spinal cord (WC) and exclusion in an isolated dorsal column white matter preparation (WM). b, Spinal cord white matter (dorsal column) homogenates (10 μg protein) were subjected to SDS-PAGE and immunoblotted with antibodies to GluR1, GluR2/3, GluR4, GluR6/7, and KA2. As illustrated,GluR4, GluR6/7, and KA2 were detected in spinal cord white matter. c, These immunoblots show equal amounts of protein loading with NF 200 and positive controls for GluR1 and _GluR2/3_using olfactory bulb.
Fig. 1.
Effect of ionotropic glutamate receptor blockade on recovery of CAP amplitude after compressive injury. APV (50 μ
m
; NMDA receptor blocker) and CNQX (10 μ
m
; AMPA/KA receptor blocker) (APV+CNQX) were administered in combination and compared with control Ringer’s solution (Ringers). a–c, Representative CAP waveforms from the APV+CNQX group recorded preinjury, 5 min postinjury, and 60 min postinjury (during washout with Ringer’s solution). d, Graph of normalized CAP amplitude versus time. Combined administration of APV (50 μ
m
) and CNQX (10 μ
m
) resulted in improved CAP amplitude recovery postinjury (significant differences in CAP amplitude shown by asterisks). At 60 min postinjury, the CAP amplitude in the APV + CNQX group had recovered to 91.5 ± 6.4% of preinjury values as compared with the_Ringers_ group (71.4 ± 2.0% of preinjury).
Fig. 2.
a, Administration of NMDA (10 μ
m
and 100 μ
m
) did not attenuate CAP recovery after traumatic injury. b, The NMDA receptor antagonist APV (50 μ
m
) did not improve recovery of CAP amplitude after compressive injury to the dorsal column segment.
Fig. 3.
Effect of 10 μ
m
CNQX or NBQX or coapplication of AMPA/KA plus antagonists (CNQX and NBQX) on CAP recovery after 2 g clip compression injury.a, Graph of normalized CAP amplitude versus time (significant differences in CAP amplitude between two groups are depicted by asterisks). At 60 min postinjury, the recovery of CAP amplitude in the CNQX group (86.5 ± 3.9% of preinjury) significantly exceeded that of the control Ringer’s solution group (Ringers) (71.4 ± 2.0% of preinjury; p < 0.05). b, Graph of normalized CAP amplitude versus time (significant differences in CAP amplitude between two groups are depicted by asterisks). At 60 min postinjury the recovery of CAP amplitude in the_NBQX_ group (85.6 ± 2.7% of preinjury) significantly exceeded that of the control Ringers group (71.4 ± 2.0% of preinjury; p < 0.05).c, Graph of normalized CAP amplitude versus time (significant differences in CAP amplitude between two groups are depicted by asterisks). At 60 min postinjury the recovery of CAP amplitude in the coapplication group (88.2 ± 7.8% of preinjury) significantly exceeded that of the control_Ringers_ group (71.4 ± 2.0% of preinjury;p < 0.05).
Fig. 4.
Effect of AMPA (100 μ
m
) and kainic acid (100 μ
m
) on CAP amplitude after 2 _g_clip compression injury. Both AMPA and Kainic Acid resulted in significant exacerbation of traumatic axonal injury when compared with control Ringer’s solution group (Ringers) (asterisks denote significant differences at p < 0.05).
Fig. 5.
Longitudinal sections through spinal cord dorsal column stained for AMPA/KA receptors by the Co2+uptake technique. Scale bar, 20 μm. a, Two darkly stained astrocytes are shown (arrows). Section incubated with 100 μ
m
kainic acid and 100 μ
m
AMPA before histochemical processing. b, Control section (without AMPA/KA stimulation) of spinal cord dorsal column white matter showing background staining only. c, A darkly stained astrocyte is shown (arrow) in injured dorsal column (untreated with AMPA/KA). d, A dorsal column white matter preparation treated with CNQX and NBQX after clip compression injury showing no Co2+ uptake staining.
Fig. 7.
The presence of GluR4 (A, B), GluR6/7 (C), and KA2 (D) immunoreactivity (FITC labeling shown as green) in 10 μm sections of thoracic spinal cord dorsal column. Double labeling with GFAP (Texas Red) confirmed these immunopositive cells to be astrocytes (arrows). Scale bars, 50 μm.
Similar articles
- Membrane currents evoked by ionotropic glutamate receptor agonists in rod bipolar cells in the rat retinal slice preparation.
Hartveit E. Hartveit E. J Neurophysiol. 1996 Jul;76(1):401-22. doi: 10.1152/jn.1996.76.1.401. J Neurophysiol. 1996. PMID: 8836233 - Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro.
Zeman S, Lodge D. Zeman S, et al. Br J Pharmacol. 1992 Jun;106(2):367-72. doi: 10.1111/j.1476-5381.1992.tb14342.x. Br J Pharmacol. 1992. PMID: 1382781 Free PMC article. - Region-specific expression of subunits of ionotropic glutamate receptors (AMPA-type, KA-type and NMDA receptors) in the rat spinal cord with special reference to nociception.
Furuyama T, Kiyama H, Sato K, Park HT, Maeno H, Takagi H, Tohyama M. Furuyama T, et al. Brain Res Mol Brain Res. 1993 Apr;18(1-2):141-51. doi: 10.1016/0169-328x(93)90183-p. Brain Res Mol Brain Res. 1993. PMID: 8097549 - Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
Kristensen BW, Noraberg J, Zimmer J. Kristensen BW, et al. Brain Res. 2001 Oct 26;917(1):21-44. doi: 10.1016/s0006-8993(01)02900-6. Brain Res. 2001. PMID: 11602227 - Characterization of the glutamate receptors mediating release of somatostatin from cultured hippocampal neurons.
Fontana G, De Bernardi R, Ferro F, Gemignani A, Raiteri M. Fontana G, et al. J Neurochem. 1996 Jan;66(1):161-8. doi: 10.1046/j.1471-4159.1996.66010161.x. J Neurochem. 1996. PMID: 8522949
Cited by
- Aberrant glutamatergic systems underlying impulsive behaviors: Insights from clinical and preclinical research.
Yates JR. Yates JR. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Dec 20;135:111107. doi: 10.1016/j.pnpbp.2024.111107. Epub 2024 Aug 2. Prog Neuropsychopharmacol Biol Psychiatry. 2024. PMID: 39098647 Review. - Stem Cell Therapy and Thiamine Deficiency-Induced Brain Damage.
Hazell AS. Hazell AS. Neurochem Res. 2024 Jun;49(6):1450-1467. doi: 10.1007/s11064-024-04137-5. Epub 2024 May 9. Neurochem Res. 2024. PMID: 38720090 Review. - Riluzole is Effective on Spinal Decompression for Treating Acute Spinal Injury When Compared With Methylprednisolone and the Combination of Two Drugs: In Vivo Rat Model.
Onder C, Onder C, Akesen S, Yumusak E, Akesen B. Onder C, et al. Global Spine J. 2024 Sep;14(7):1899-1908. doi: 10.1177/21925682231159068. Epub 2023 Feb 22. Global Spine J. 2024. PMID: 36812057 Free PMC article. - Protective role of muscones on astrocytes under a mechanical-chemical damage model.
Li RF, Gui F, Yu C, Luo YM, Guo L. Li RF, et al. Ann Transl Med. 2022 Sep;10(17):927. doi: 10.21037/atm-22-3848. Ann Transl Med. 2022. PMID: 36172099 Free PMC article. - Combined cell grafting and VPA administration facilitates neural repair through axonal regeneration and synaptogenesis in traumatic brain injury.
Liu S, Tian H, Niu Y, Yu C, Xie L, Jin Z, Niu W, Ren J, Fu L, Yao Z. Liu S, et al. Acta Biochim Biophys Sin (Shanghai). 2022 Sep 25;54(9):1289-1300. doi: 10.3724/abbs.2022123. Acta Biochim Biophys Sin (Shanghai). 2022. PMID: 36148950 Free PMC article.
References
- Agrawal SK, Fehlings MG. Mechanisms of calcium mediated axonal injury after spinal cord trauma. Soc Neurosci Abstr. 1995;21:381.
- Barres BA, Koroshetz WJ, Swartz KJ, Chun LLY, Corey DP. Ion channel expression by white matter glia: the O-2A glial progenator cell. Neuron. 1990;4:507–524. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous